Evaluation of Efficacy, Safety, and Cognitive Profile of Amisulpride Per Se and Its Comparison with Olanzapine in Newly Diagnosed Schizophrenic Patients in an 8-Week, Double-Blind, Single-Centre, Prospective Clinical Trial

DOI: 10.5402/2012/703751

Full-Text   Cite this paper   Add to My Lib

Abstract:

Full-Text